Besivance Suspension
Product Images NDC 82260-466
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Besivance (NDC 82260-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch & Lomb Americas Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (Carton)
This is a description of Besifloxacin Ophthalmic Suspension 0.6%. It contains besifloxacin as the active ingredient and benzalkonium chloride as a preservative. The suspension is distributed by Bausch & Lomb Americas Inc. and manufactured by Bausch & Lomb Incorporated. The usual dosage is one drop in the affected eye(s) three times a day for 7 days. The product should be stored between 15°C to 25°C and protected from light. It is important to shake the closed bottle before use. This ophthalmic suspension is for topical use only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.